Dopaminergic involvement in the mechanism of action of pentazocine.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003216:Conditioning, Operant / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D009020:Morphine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009270:Naloxone / Q000494:pharmacology; D009619:Nociceptors / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D010423:Pentazocine / Q000494:pharmacology*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D011957:Receptors, Opioid / Q000187:drug effects; D012653:Self Stimulation / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects
D011954:Receptors, Dopamine; D011957:Receptors, Opioid; D009270:Naloxone; D009020:Morphine; D010423:Pentazocine; D004298:Dopamine; D009638:Norepinephrine